We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Image: The global market for clinical chemistry analyzers is expected to reach USD 16.0 billion by 2025 (Photo courtesy of Medgadget).

Global Analyzer Market to Reach USD 16.0 Billion by 2025

The global market for clinical chemistry analyzers is expected to reach USD 16.0 billion by 2025, driven by their increased adoption due to the growing prevalence of chronic diseases, fueled further by an increasing geriatric and bariatric population, which is highly susceptible to chronic diseases. The resulting high sample volume requiring high capability analyzing devices will drive the growth of the global clinical chemistry analyzers market, going forward. More...
31 Mar 2017

Streck Enters Distribution Agreement with Dow Biomedica

Streck, Inc., which develops and manufactures products for clinical and research laboratories, has entered into a distribution agreement for its cell stabilization, molecular and flow cytometry products with Dow Biomedica, a distributor of diagnostic products specializing in immunology, microbiology and QC materials. More...
31 Mar 2017

Greiner Bio-One to Serve Spain and Portugal through Distribution Subsidiaries

Greiner Bio-One has acquired its long-standing distribution partners, VacuetteEspaña and Vacuette Portugal, which will now allow the medical technology company to serve its customers in Spain and Portugal directly through its own distribution subsidiaries. More...
28 Mar 2017

POCT Market Reaches USD 18 Billion in 2016

Sales of point of care (POC) diagnostic testing, both professional testing and self-testing, reached USD 18.4 billion in 2016, driven by emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices that aim to provide expedited diagnosis where the patient is seen or in the patient’s home. These new technologies are allowing POC devices to generate quantitative lab-quality test results and transfer them automatically to an information system, a remote caregiver service for consultation or an electronic medical record. More...
10 Mar 2017

Collaboration Improves Diagnosis and Monitoring of Multiple Myeloma

The Binding Site Group Ltd. has entered into a collaboration agreement with Mayo Clinic to develop a clinical laboratory test for the identification and accurate measurement of monoclonal proteins present in B-cell diseases. Both the organizations have been involved in collaborative activities for more than two decades with the aim of improving the testing, diagnosis and monitoring of patients with multiple myeloma and related conditions. The output of the latest collaboration will build on combining The Binding Site’s antibody- and assay-development expertise with Mayo Clinic’s clinical excellence and its recently patented approach to improving multiple myeloma patient monitoring. More...
10 Mar 2017

Molecular Diagnostics Market Worth Nearly USD 7 Billion

The size of the molecular diagnostic testing market has reached USD 6.7 billion and is being driven by the growing threat of infectious disease and cancer, as well as the development of new products. These are the latest findings of Kalorama Information, an independent medical market research firm. More...
21 Feb 2017
Image: Siemens Healthineers has entered into a five-year contract to take over the clinical laboratory service operations for two new hospitals in Turkey (Photo courtesy of QLS).

Siemens Healthineers Commissioned to Provide Lab Services for Turkish Hospitals

Siemens Healthineers has entered into a five-year contract to take over the clinical laboratory service operations for two new hospitals in Turkey. The hospitals in Bilkent, Ankara, and in Mersin are being built and operated as Public Private Partnership (PPP) by DiA Construction, a subsidiary of DiA, for the Turkish Ministry of Health. More...
09 Feb 2017
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.